Telitacicept (RC18) is a fully human TACI-Fc fusion protein. Telitacicept is a dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation-inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. Telitacicept can be used in research of B-cell autoimmune disease[1]. The component ratio of this product is Active ingredient : Excipients = 1: 0.5-1: 0.8.
Molecular Weight:
(75.36 kDa)
Purity:
99.30
CAS Number:
[2136630-26-5]
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
